Pharma
Apollo Therapeutics closes $226.5 Million Series C financing led by Patient Square Capital
CAMBRIDGE, UK & BOSTON, US – Apollo Therapeutics, a portfolio biopharmaceutical company focused on translating fundamental medical research into medicines through a hub-and-spoke approach, announces the close of $226.5 million in a Series C financing led by lead investor Patient Squ...
Cresset Discovery shares insights on escaping fluorinated chemical space
Introduction At Cresset Discovery the team endeavour to remain up to date with the changing development landscape, exploring new methods and techniques but also examining trends and problems that are approaching. It was this approach to analysis, and following discussions with our clie...
Essential building blocks for business success from founder of Axiom-e
Last term, Ken Dickson, the founder of Axiom-e, ran three versions of 'The Pillars of Business Success' course to audiences drawn from more than 20 countries. His first talk of this term will be at the Quadram Institute, a state-of-the-art facility for bioscience and clinical research,...
Skeletal editing and removing the gap between CADD/AIDD and synthesis
In the fields of peptide and protein synthesis, there is a very efficient translation between design and synthesis – this operates generally via the mechanism of DNA synthesis, and then various expression platforms or through direct synthesis routes at the amino acid level. Whilst the ‘...
Moving on up: Guardtech Group celebrate continued growth with switch to stunning new home
Cleanroom construction experts putting finishing touches on impressive new Guardtech House HQ in Haverhill. ...
NIHR BioResource - Celebrating our Centres - Birmingham
The NIHR BioResource Centre Birmingham team have been busy on the ground engaging with local communities at events, talking about the NAFLD BioResource and patient participation on local radio, and getting professional videos made to promote diversity, participation and the value of res...
Living with SANDO – a long road to diagnosis
42-year-old Mark shares his story living with Sensory Ataxic Neuropathy, Dysarthria, and Ophthalmoparesis (SANDO) disease, a rare mitochondrial condition that affects the brain, muscles, nerves and eyes. He discusses everything from the long road to diagnosis, his brother developing sym...
Optibrium acquires BioPharmics LLC, expanding its 3D drug design and visualisation offering
BioPharmics’ Drs Ajay Jain (CEO) and Ann Cleves (Director of Applied Science) join the Optibrium team as Vice Presidents in the newly-created BioPharmics Division. ...
NIHR IMID BioResource recruits its 10,000th volunteer in major milestone
The platform for research into Immune-Mediated Inflammatory Diseases (IMIDs) has now signed up 10,000 participants nationwide. Find out about the value of having such a large cohort and what it means for future research studies into IMIDs. ...
Key human bladder cancer genes pinpointed in cats and dogs
Key bladder cancer genes have been uncovered through studying the cancers in cats and dogs, in a significant stride for finding which of many mutations are the most important in the cancer’s development. ...